Certolizumab pegol for the treatment of rheumatoid arthritis

Author： Modesto I Spinello M Nicchi F Cottone M

ISSN： 1475-0708

Source： Therapy, Vol.8, Iss.4, 2011-07, pp. : 391-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 2, 2015-02 ,pp. : 151-160

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 12, 2015-12 ,pp. : 3104-3112

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of early rheumatoid arthritis

By Raza Karim Salmon Mike Buckley Christopher D

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 659-668

Future Medicine

Access to resources Recommend Favorite

Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24‐Week Patient‐Reported Outcome Results of a Phase III, Multicenter Study

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 1085-1092

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7‐year PRECiSE 3 study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 330-342

John Wiley & Sons Inc

Access to resources Recommend Favorite